Diabetic Foot Clinical Trial
Official title:
Application of a Double Blind Clinical Trial Protocol for Evaluation of Healing Action of P1G10, From V Cundinamarcensis to Chronic Neuropathic Wounds in Diabetic Foot Ulcers.
The aim of the study was to investigate the role of the proteolytic fraction from Vasconcellea cundinamarcensis, designated as P1G10, on healing of chronic foot ulcers in neuropathic patients diagnosed with diabetes type 2. Fifty patients were enrolled in a prospective, randomized, double-blind trial, to verify the efficacy and safety of a topical dressing containing 0.1% P1G10, versus a Hydrogel (positive control) protocol currently applied at the Health Center to treat this condition. Upon completion of the intervention, the outcome evaluated the number of patients attaining full epithelization (100%), or at least 80% healing in both arms (P1G10 versus Hydrogel). Statistical analysis compared the endpoint data on each group to assess the significance of differences.
Volunteers admitted for the study were randomly assigned into two distinct treatment groups.
Randomization was performed by simple and stratified draw for each type of treatment. The
treatment options were: a) Hydrogel™ and b) P1G10. The active principle had been previously
dissolved in water and dispersed into Polawax dressing at 0.1% w/w final. Polawax™ is an
emulsifying wax for cosmetic preparations. According to the manufacturers, it is able to hold
together all types of ingredients without residue or separation. It is, therefore, ideal for
"oil in water" creams and lotions. Number were used to identify both formulations.
The staff participating in this clinical trial, including researchers was unaware of the
identity of the formulation applied on each proband. Each formulation used during the
intervention was dispensed weekly at the Laboratory of Antitumor Substances of the Institute
of Biological Sciences of the Federal University of Minas Gerais by members of the research
group who had no contact with the staff responsible for the application of the protocol. The
formulations were stored at 4°C until its application.
The treatment and the collection of data, took place between August 2012 and October 2016,
and it was carried out by health professional and a technical assistant previously trained to
evaluate and perform the procedure.
The application of the intervention was done three times per week (Monday, Wednesday and
Friday), completing 48 applications or until full epithelialization of the ulcer was
observed, whichever occurred first. The treatment was performed exclusively at the outpatient
level. When the proband could not attend the scheduled treatment, he (she) was instructed to
perform the dressing change only with 0.9% saline solution. Patients who missed two
consecutive scheduled interventions were withdrawn from the study.
Ulcers were cleaned with 0.9% physiological solution using soft pressure, without scrubbing
or addition of antiseptic substances. Subsequently, a thin layer of the ointment containing
P1G10 or Hydrogel was applied over the ulcer bed, covering all its extension. Then double
gauze was applied, fixed with adhesive tape and crepe bandage, if necessary. In cases of
users with more than one wound, each wound received identical treatment, but only one ulcer
was selected for the study.
During the first week of treatment, the subjects were observed for 30 minutes after the
intervention, in order to verify possible undesirable effects. After this interval, if they
did not present adverse events, they were released. Users were also instructed to contact the
responsible investigators by telephone if they observed the emergence of any adverse effects.
A prior trial of the formulation containing 0.1% P1G10 applied onto the arm of healthy
individuals during one-month did not induce local or systemic affects.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06154915 -
Immune Cells in Diabetic Chronic Foot Ulcers
|
||
Completed |
NCT04624516 -
Effect of Self-foot Exercise on the Incidence of Plantar Foot Diabetic Ulcer Recurrence
|
N/A | |
Not yet recruiting |
NCT06278935 -
Lifestyle Tailored Offloading for Diabetic Foot Ulcers
|
N/A | |
Completed |
NCT02373592 -
Implementation of Foot Thermometry and SMS and Voice Messaging to Prevent Diabetic Foot Ulcer
|
N/A | |
Active, not recruiting |
NCT01903044 -
Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia Treating
|
Phase 1/Phase 2 | |
Completed |
NCT02092870 -
Adipose Derived Regenerative Cellular Therapy of Chronic Wounds
|
Phase 2 | |
Completed |
NCT01212120 -
The Foot in Your Nose Study: Links Between Nasal Staphylococcus Aureus Colonies and Diabetic Foot Lesion Infections
|
N/A | |
Completed |
NCT00402727 -
Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection
|
Phase 3 | |
Recruiting |
NCT04085705 -
The Prevalence of Contact Allergies for Wound Dressings In Patients With Diabetic Foot Ulcers (PAID Study)
|
||
Completed |
NCT04054804 -
Digital Foot Check by Using the D-Foot, a New Software
|
||
Completed |
NCT04480801 -
The Effect of Thermal Evaluation in Prevention of Diabetic Foot Ulcer
|
N/A | |
Not yet recruiting |
NCT04537676 -
Patient Empowerment Study
|
||
Recruiting |
NCT04564443 -
A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot
|
N/A | |
Recruiting |
NCT05974592 -
The Effect of Nurse-Led Diabetic Foot Self-Management Training Program
|
N/A | |
Not yet recruiting |
NCT04630795 -
ViscoTurf - Preventing Secondary Diabetic Foot Ulceration.
|
||
Not yet recruiting |
NCT05431660 -
Diabetic Foot School and Biomechanics
|
N/A | |
Completed |
NCT05101473 -
Exercise Therapy for People With a Diabetic Foot Ulcer - a Feasibility Study
|
N/A | |
Completed |
NCT05123157 -
Pattern and Type of Amputation and Mortality Rate Associated With Diabetic Foot in Jeddah, Saudi Arabia: A Retrospective Cohort Study
|
||
Enrolling by invitation |
NCT05043636 -
Diabetic Neuropathy Screening Study 1.1 + Substudy 1.2-1.3-1.4
|
||
Completed |
NCT03254095 -
Predictors of Skin Temperature, Plantar Pressure and Ulceration in Diabetic Foot Patients.
|